Renaissance Technologies LLC Sells 20,200 Shares of iShares Biotechnology ETF $IBB

Posted by Donald Scott on Aug 15th, 2026

Renaissance Technologies LLC lowered its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 76.5% during the first quarter, Holdings Channel.com reports. The institutional investor owned 6,200 shares of the financial services provider’s stock after selling 20,200 shares during the quarter. Renaissance Technologies LLC’s holdings in iShares Biotechnology ETF were worth $1,047,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the stock. Basepoint Wealth LLC acquired a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at approximately $26,000. Cary Street Partners Financial LLC bought a new position in iShares Biotechnology ETF during the 4th quarter worth approximately $29,000. Darwin Wealth Management LLC acquired a new position in iShares Biotechnology ETF during the second quarter valued at approximately $25,000. Caitlin John LLC acquired a new position in iShares Biotechnology ETF during the fourth quarter valued at approximately $34,000. Finally, Cornerstone Planning Group LLC bought a new stake in iShares Biotechnology ETF in the fourth quarter valued at approximately $35,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 0.3%

IBB opened at $198.26 on Friday. The firm’s fifty day moving average is $186.87 and its two-hundred day moving average is $176.26. iShares Biotechnology ETF has a twelve month low of $136.89 and a twelve month high of $201.72.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Monday, June 15th were issued a $0.0238 dividend. This represents a $0.10 annualized dividend and a dividend yield of 0.0%. The ex-dividend date was Monday, June 15th.

iShares Biotechnology ETF Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.